ANSWER: The term “lupus” generally means systemic lupus erythematosis (SLE), which is a systemic disorder (as its name ...

Lupus is an autoimmune condition. It has a variety of symptoms and can affect many body parts. It is difficult to diagnose. Treatment can help manage symptoms.

Systemic lupus erythematosus (SLE) is a chronic condition that can affect multiple tissues and organs. Learn about symptoms, causes, treatments, and more.

The study initially included a total of 115 SLE patients and 115 controls, with median age 43 at baseline. Follow-up visits were scheduled at years 3, 7, and 10.

Numerous cases and case series presented at EULAR 2024 add to a rapidly growing collection of evidence that CAR T-cell therapy will be a meaningful option in SLE and other rheumatic diseases.

At last follow-up (4-22 months), all seven had SLE Disease Activity Index scores of 0 and were in clinical remission under Definition of Remission in SLE criteria.

Have been diagnosed with active SLE. Are taking at least one background therapy (immunosuppressant and/or antimalarial) for at least 12 weeks before the screening visit and must be on a stable dose ...

We conducted a phase 2 trial of litifilimab involving participants with SLE. The initial trial design called for randomly assigning participants to receive litifilimab (at a dose of 50, 150, or ...

During the 10-year follow-up, patients with SLE showed a 2.3-fold higher risk for plaque progression than healthy control participants (adjusted incidence rate ratio [aIRR], 2.26; P = .002).